Clinic
Purohit Pediatric Clinic, LLC
Purohit Pediatric Clinic, LLC was paid $23.20M by Medicaid between Jan 2018 and Dec 2024, across 95 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 35% of everything it billed.
33Billing provider infoPUROHIT PEDIATRIC CLINIC, LLC
ANNISTON, AL 36201
ANNISTON, AL 36201
33aNPI1790971166assigned 09/19/2007
33bProvider typeClinic/Center
28Total paid$23.20M
24GClaims640,023
24DCodes billed95
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Alabama
Rank by total paid#2 of 57
Median peer was paid$94K
This provider vs. median246×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 70,240 | $2.20M | |
| 2019 | 84,180 | $2.64M | |
| 2020 | 75,379 | $2.44M | |
| 2021 | 102,937 | $3.90M | |
| 2022 | 116,183 | $4.12M | |
| 2023 | 104,439 | $4.09M | |
| 2024incomplete | 86,665 | $3.82M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 35% | 92,578 | 82,176 | $8.19M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 49,874 | 45,720 | $2.97M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 7.4% | 9,521 | 8,276 | $1.71M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.6% | 17,492 | 16,867 | $1.07M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.5% | 16,937 | 16,159 | $1.05M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.4% | 13,276 | 12,599 | $786K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.2% | 18,093 | 16,885 | $736K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.3% | 27,512 | 25,009 | $544K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.0% | 7,828 | 7,532 | $470K |
| 87634 | 1.8% | 9,488 | 8,765 | $416K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.7% | 16,301 | 14,434 | $395K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.7% | 4,238 | 4,032 | $389K |
83 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 28,407 | $349K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.4% | 7,225 | $315K |
| 90670 | 1.2% | 11,314 | $271K | |
| 90648 | 1.1% | 14,555 | $266K | |
| 99460 | 1.0% | 3,198 | $243K | |
| 90723 | <1% | 10,780 | $209K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 3,416 | $201K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 3,046 | $180K |
| 90680 | <1% | 7,578 | $148K | |
| 90686 | <1% | 6,365 | $117K | |
| 99173 | <1% | 30,844 | $116K | |
| 90633 | <1% | 6,222 | $116K | |
| 90716 | <1% | 5,545 | $113K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 10,949 | $111K |
| 99462 | <1% | 3,194 | $107K | |
| 90707 | <1% | 5,408 | $105K | |
| 92551 | <1% | 22,582 | $99K | |
| 99401 | <1% | 3,136 | $90K | |
| 54150 | <1% | 654 | $89K | |
| 90461 | <1% | 1,662 | $88K | |
| D1206 | Topical application of fluoride varnish | <1% | 5,071 | $80K |
| 90651 | <1% | 3,490 | $77K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 610 | $73K |
| 90671 | <1% | 3,328 | $73K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,588 | $67K |
| 90734 | <1% | 2,854 | $62K | |
| 83655 | <1% | 4,457 | $61K | |
| 96127 | <1% | 14,738 | $55K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,468 | $40K |
| 92552 | <1% | 1,405 | $37K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 625 | $34K |
| 90696 | <1% | 1,563 | $29K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 232 | $28K |
| 90700 | <1% | 1,504 | $28K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 309 | $26K |
| 90688 | <1% | 1,471 | $26K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 218 | $24K |
| 90715 | <1% | 1,252 | $23K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,000 | $21K |
| 87807 | <1% | 2,007 | $21K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,241 | $21K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,426 | $19K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,999 | $17K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 1,078 | $17K |
| 80061 | Lipid panel | <1% | 1,262 | $16K |
| 96161 | <1% | 7,344 | $13K | |
| 90620 | <1% | 656 | $12K | |
| 69210 | <1% | 492 | $12K | |
| 90681 | <1% | 578 | $11K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 181 | $11K |
| 36416 | <1% | 33,449 | $10K | |
| 80053 | Comprehensive metabolic panel | <1% | 918 | $10K |
| 81003 | <1% | 2,959 | $8K | |
| 0001A | <1% | 209 | $7K | |
| 0002A | <1% | 195 | $7K | |
| 90656 | <1% | 408 | $7K | |
| 0072A | <1% | 162 | $6K | |
| 99464 | <1% | 119 | $6K | |
| 0071A | <1% | 158 | $6K | |
| 94060 | <1% | 161 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 276 | $5K |
| 86580 | <1% | 594 | $3K | |
| 86308 | <1% | 610 | $3K | |
| 74018 | <1% | 156 | $3K | |
| 82247 | <1% | 545 | $2K | |
| 99051 | <1% | 7,446 | $2K | |
| 85018 | <1% | 9,864 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 47 | $2K |
| 96160 | <1% | 1,085 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,297 | $1K |
| 99177 | <1% | 146 | $1K | |
| 94010 | <1% | 69 | $1K | |
| 94664 | <1% | 101 | $902.00 | |
| 99383 | <1% | 15 | $770.00 | |
| 0081A | <1% | 12 | $480.00 | |
| 90685 | <1% | 12 | $237.48 | |
| 82947 | <1% | 42 | $160.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,786 | $149.20 |
| 81025 | <1% | 44 | $119.60 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 97 | $41.98 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 31,305 | $30.00 |
| 91307 | 0% | 12 | $0.00 | |
| 91300 | 0% | 59 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPUROHIT, NARESH (OWNER/MD)